April 26, 2016 — Auris Surgical Robotics Inc. and Hansen Medical Inc. announced that they have signed a definitive merger agreement under which Auris will acquire Hansen Medical for $4.00 per share in cash. The total equity value of the deal is approximately $80 million.
The purchase price per share represents a premium of approximately 39.9 percent over the closing sale price of common stock of Hansen Medical as reported on NASDAQ on April 19, 2016. In addition, certain significant stockholders of Hansen Medical have agreed to invest approximately $49 million into Auris contemporaneously with the closing of the transaction.
The transaction is expected to close in mid-2016, subject to customary closing conditions, including Hansen Medical shareholder approval. Holders of approximately 65.4 percent of Hansen Medical's outstanding shares, including all executive officers and directors of Hansen Medical and the significant stockholders described above, have entered into voting agreements with Auris and Hansen Medical pursuant to which they have agreed to vote in favor of and otherwise support the transaction.
Auris is a technology company combining advancements in medical robotics, instrumentation, navigation and data science to build a platform technology capable of expanding the applicability of robotics to a spectrum of medical procedures.
Hansen Medical Inc. develops intravascular robotics products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The company's Magellan Robotic System, Magellan Robotic Catheters and related accessories are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices.
For more information: www.hansenmedical.com, www.aurisrobotics.com
March 18, 2024 
